510 related articles for article (PubMed ID: 17183611)
1. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
3. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
4. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response.
Kedl RM; Mescher MF
J Immunol; 1998 Jul; 161(2):674-83. PubMed ID: 9670942
[TBL] [Abstract][Full Text] [Related]
5. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals.
Song A; Song J; Tang X; Croft M
Eur J Immunol; 2007 May; 37(5):1224-32. PubMed ID: 17429847
[TBL] [Abstract][Full Text] [Related]
7. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
8. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.
Mercier BC; Cottalorda A; Coupet CA; Marvel J; Bonnefoy-Bérard N
J Immunol; 2009 Feb; 182(4):1860-7. PubMed ID: 19201838
[TBL] [Abstract][Full Text] [Related]
9. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA
J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827
[TBL] [Abstract][Full Text] [Related]
10. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
[TBL] [Abstract][Full Text] [Related]
11. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
Bourgeois C; Rocha B; Tanchot C
Science; 2002 Sep; 297(5589):2060-3. PubMed ID: 12242444
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transcription factor lung Krüppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo.
Schober SL; Kuo CT; Schluns KS; Lefrancois L; Leiden JM; Jameson SC
J Immunol; 1999 Oct; 163(7):3662-7. PubMed ID: 10490960
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD3 priming generates heterogeneous antigen-specific memory CD4 T cells.
Patke DS; Ahmadzadeh M; Bingaman AW; Farber DL
Clin Immunol; 2005 Nov; 117(2):125-32. PubMed ID: 16143567
[TBL] [Abstract][Full Text] [Related]
14. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.
Maile R; Pop SM; Tisch R; Collins EJ; Cairns BA; Frelinger JA
Eur J Immunol; 2006 Feb; 36(2):397-410. PubMed ID: 16402405
[TBL] [Abstract][Full Text] [Related]
15. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection.
Kim SK; Schluns KS; Lefrançois L
J Immunol; 1999 Oct; 163(8):4125-32. PubMed ID: 10510347
[TBL] [Abstract][Full Text] [Related]
16. Optimising anti-tumour CD8 T-cell responses using combinations of immunomodulatory antibodies.
Gray JC; French RR; James S; Al-Shamkhani A; Johnson PW; Glennie MJ
Eur J Immunol; 2008 Sep; 38(9):2499-511. PubMed ID: 18792403
[TBL] [Abstract][Full Text] [Related]
17. Frontline: An in-depth evaluation of the production of IL-2 by antigen-specific CD8 T cells in vivo.
D'Souza WN; Lefrançois L
Eur J Immunol; 2004 Nov; 34(11):2977-85. PubMed ID: 15384078
[TBL] [Abstract][Full Text] [Related]
18. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
[TBL] [Abstract][Full Text] [Related]
19. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
Huddleston CA; Weinberg AD; Parker DC
Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
[TBL] [Abstract][Full Text] [Related]
20. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
